3. The synergistic effect of choline and inositol on liver lipids has been confirmed.
biol. Chem. 148, 275. King, E. J. (1932 An approach to the chemotherapy of malaria from the point of view of antagonism of essential growth factors presents the difficulty that the requirements of essential factors by the malaria parasites are unknown. However, as a large number of drugs has been tested for antimalarial activity, it was thought that a study of the essential metabolites antagoniLzed by them, with reference to an organism more easily handled in vitro than the malaria parasite, might throw some light on the mode of action of antimalarial drugs. Riboflavin was selected for initial work as bearing some structural resemblance to the acridine antimalarials ( Fig. 1) , and Lactobacillu8 ca8ei e as the test organism because it requires an extraneous supply of riboflavin for its growth. Of a number of substances tested as riboflavin inhibitors, only those which are antimalarials have now been shown to be antagonized by riboflavin.
EXPERIMENTAL
Organi8m. Lactobacillus cawc isknown to require an extraneous source of riboflavin for itg growth and was used as test organism.
Medium. The medium used was essentially that described by Snell & Strong (1939) for the quantitative assay of riboflavin. It contains: photolyzed NaOH-treated peptone 0-5 %, glucose 1 %, Na acetate 0-6 %, cystine 0-01 %, inorganic salts and a riboflavin-free yeast supplement.
In the present work Evans's peptone (Evans, Song, Lescher and Webb) was used instead of Difco Bactopeptone, and the riboflavin-free yeast supplement prepared as follows: Marmite (100 g.) in water (150 ml.) was treated with basic Pb acetate (250 ml. 10 %) and filtered. The clear filtrate was made alkaline (pH 10) with ammonia and the resulting precipitate discarded. The Pb salts were removed with H2S, the PbS filtered and the H2S removed by a current of air. Five ml. of this clear solution were used for each 250 ml. medium. The medium prepared in this way produces a very slight, but definite, growth of L. casei. Addition of riboflavin up to 0-05j&g./ml. caused an increase of growth, with no further increase with larger quantities of riboflavin. The growth was measured turbidimetrically.
Method for ob8erving the effect of riboflavin on the growth inhibitory action of some drugs Double-strength medium, prepared according to Snell & Strong (1939) , was adjusted to pH 6-8. Two parts of this medium were mixed with one part of riboflavin solution (100 l g./ml. in 0-02M acetic acid). Two further parts of the original medium were rnixed with one part of a more dilute solution of riboflavin (lug./ml.). After sterilizing in the autoclave, both media were bulk inoculated with a 24 hr. old culture of L. casei (0 1 ml./1000 ml.) in a medium containing 2.5,ug./ml. riboflavin. Such cultures for inoculum were prepared weekly from stock cultures of L. casei which were carried in a stab culture in agar yeast water glucose medium. Both stock and inoculum cultures were kept in the refrigerator.
Suitable consecutive falling twofold dilutions of the drug to be assayed (in 0 5 ml.) were placed in parallel series of tubes. To one of these series 1-5 ml. of the bulk inoculated medium, rich in riboflavin, was added. The other received the same amount of the medium with less riboflavin. After incubation for 18-24 hr. at 370 an inspection for whether or not growth had taken place was made. In dubious cases an experiment was repeated, but instead of twofold dilutions of the drug closer dilutions were used, usually the concentration differing by a factor of 0 7. RESULTS Table 1 shows a typical experiment using Mepacrine and dl-pantoyltaurine as antagonists of growth promoted by riboflavin. Table 3 . Antagoni8m of 3349 (see Signs have same significance as in growth; -no detectable growth; tr. Which of the components of these coenzymes are to produce a sediment which, when lium, did not render it appreciably synthesized by the parasites themselves and on which they are dependent of an external supply is not known. The antagonism by some chemotherae concentration (mg./ml.) in the peutic agents of essential metabolites which may growth in media containing 2-5 play a role in enzyme systems has been given as an iboflavin.
explanation of the mode of action of these drugs. Effect of concentrations of ribo-The similarity of the shape of the molecule of the and 2.5 .tg./ml., media contain-antagonizing agent to the metabolite appears in its of this substance were bulk some cases to be the reason for the action of the led to dilutions of the drug in drug. The similarity of the formal structure of ribo-)usly described. Table 3 shows flavin with that of some antimalarial drugs, such as led when the drug was 3349. Mepacrine (atebrine), 2666, 3349 and 3502 (Fig. 1) epacrine, 2666 and 3502 the has already been pointed out (Curd, Davey & Rose, were similar, differing only in 1944).
Of drug required to suppress the The examination of these and other antimalarial drugs as riboflavin antagonists using L. casei e as a test organism shows ( flavin. This is different from the sulphanilyl drugsp-aminobenzoic acid and the pantoyltaurinepantothenic acid antagonisms, where the antagonistic drug exerts its action over a wide range of concentrations of the essential factors. It is difficult to picture the precise mode of the antagonism of the antimalarial drugs by riboflavin. Riboflavin has to combine with other low molecular substances before becoming a coenzyme. At the moment there is not enough evidence to decide whether the action of drugs which antagonize riboflavin is in preventing the synthesis of a coenzyme or a competition with the coenzyme for the apoenzyme.
SUMMARY
Of a number of substances tested as riboflavin inhibitors, only those which are antimalarials were antagonized by riboflavin, using L. casei e as test organism.
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